完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Ali, Imran | en_US |
dc.contributor.author | Alsehli, Mosa | en_US |
dc.contributor.author | Scotti, Luciana | en_US |
dc.contributor.author | Scotti, Marcus Tullius | en_US |
dc.contributor.author | Tsai, Shang-Ting | en_US |
dc.contributor.author | Yu, Ruei-Siang | en_US |
dc.contributor.author | Hsieh, Ming Fa | en_US |
dc.contributor.author | Chen, Jung-Chih | en_US |
dc.date.accessioned | 2020-07-01T05:21:18Z | - |
dc.date.available | 2020-07-01T05:21:18Z | - |
dc.date.issued | 2020-03-01 | en_US |
dc.identifier.uri | http://dx.doi.org/10.3390/polym12030598 | en_US |
dc.identifier.uri | http://hdl.handle.net/11536/154384 | - |
dc.description.abstract | Cancer is a life-threatening disease killing millions of people globally. Among various medical treatments, nano-medicines are gaining importance continuously. Many nanocarriers have been developed for treatment, but polymerically-based ones are acquiring importance due to their targeting capabilities, biodegradability, biocompatibility, capacity for drug loading and long blood circulation time. The present article describes progress in polymeric nano-medicines for theranostic cancer treatment, which includes cancer diagnosis and treatment in a single dosage form. The article covers the applications of natural and synthetic polymers in cancer diagnosis and treatment. Efforts were also made to discuss the merits and demerits of such polymers; the status of approved nano-medicines; and future perspectives. | en_US |
dc.language.iso | en_US | en_US |
dc.subject | theranostic cancer treatment | en_US |
dc.subject | polymeric nanoparticles | en_US |
dc.subject | merits and demerits | en_US |
dc.subject | approved nano-medicines | en_US |
dc.subject | future perspectives | en_US |
dc.title | Progress in Polymeric Nano-Medicines for Theranostic Cancer Treatment | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.3390/polym12030598 | en_US |
dc.identifier.journal | POLYMERS | en_US |
dc.citation.volume | 12 | en_US |
dc.citation.issue | 3 | en_US |
dc.citation.spage | 0 | en_US |
dc.citation.epage | 0 | en_US |
dc.contributor.department | 分子醫學與生物工程研究所 | zh_TW |
dc.contributor.department | Institute of Molecular Medicine and Bioengineering | en_US |
dc.identifier.wosnumber | WOS:000525952000097 | en_US |
dc.citation.woscount | 1 | en_US |
顯示於類別: | 期刊論文 |